Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis

PaperCitations, authors & open-access status

Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 30 citations, 2023 year and hybrid oa status.

30
Citations
2023
Year
hybrid
OA Status

Related on ScholarIQ

Yong Kek Pang
Author
Journal of Thoracic Oncology
Journal
Brain Metastases and Treatment
Topic
Brain Metastases and Treatment
Topic
Lung Cancer Treatments and Mutations
Topic
Head and Neck Cancer Studies
Topic
470M+ articles · free account